Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

F. Hoffmann-La Roche Ltd - Redefining Lung Cancer Together: Now and Next

Treatment choice in early-stage lung cancer: new insights, new outlooks

Date

11 Sep 2022

Session

F. Hoffmann-La Roche Ltd - Redefining Lung Cancer Together: Now and Next

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Paul van Schil

Authors

M. Reck1, P.E. van Schil2

Author affiliations

  • 1 Thoracic Oncology Dept., Krankenhaus Grosshansdorf, 22927 - Grosshansdorf/DE
  • 2 Department Of Thoracic And Vascular Surgery, UZA - University Hospital Antwerp, 2650 - Edegem/BE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and Introduction

Presenter: Stephen Liu

Session: F. Hoffmann-La Roche Ltd - Redefining Lung Cancer Together: Now and Next

Resources:

Webcast

Panel discussion and Q&A

Presenter: Stefania Vallone

Session: F. Hoffmann-La Roche Ltd - Redefining Lung Cancer Together: Now and Next

Resources:

Webcast

Conclusion

Presenter: Stefania Vallone

Session: F. Hoffmann-La Roche Ltd - Redefining Lung Cancer Together: Now and Next

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.